N/A N=203 The Place of Imaging and Microbiology in the Diagnosis of Pneumonia in the Elderly
Pneumonia
Primary: Number of Patients With Modified Diagnosis Probability After Low Dose CT (LDCT) — 10; 3; 4; 34 Participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=193 Network Support for Alcohol Treatment 2
Alcohol Consumption
Primary: Proportion Days Abstinent (PDA) — .67; .73 proportion of days abstinent — p=<.04
Phase 2 N=139 Double-blind, Vehicle-controlled Study of the Efficacy and Safety of SADBE in Subjects With Recurrent Herpes Labialis
Herpes Labialis · Cold Sore
Primary: Days to Next Herpes Labialis (Cold Sore) Episode From 43 Days After the First Dose up to 121 Days After the First Dose — 128; 163; 174 days
Phase 2 N=154 PROSTVAC (PSA-TRICOM) in Preventing Disease Progression in Patients With Localized Prostate Cancer Undergoing Active Surveillance
Stage I Prostate Adenocarcinoma AJCC v7 · Stage II Prostate Adenocarcinoma AJCC v7
Primary: Change in CD8+ Positive Cells in the Stroma Adjacent to Tumor and Within the Malignant Portion of the Prostate Biopsies — 12.2; -6.9 number of positive cells per mm^2
Phase 2 N=94 Toradol to Reduce Ureteroscopic Symptoms Trial
Urinary Lithiasis · Kidney Diseases · Kidney Stone
Primary: Post-operative Pain — 22; 30 milligram morphine equivalent
N/A N=60 Assessment of a Novel Tracheostomy Tie
Tracheostomy Complication
Primary: Visual Analogue Scale to Measure the Difficulty Level of Exchanging or Cleaning the Tracheostomy Ties (0 to 10 ) Higher Scores Mean a Worse Outcome — 1.2; 7.5 score on a…
Phase 2 N=91 Cognitive Effects of Oral p38 Alpha Kinase Inhibitor Neflamapimod in Dementia With Lewy Bodies
Dementia With Lewy Bodies (DLB)
Primary: Composite Z-score of a Study-specific Neuropsychological Test Battery (NTB) Including Tests From Cogstate Battery, Letter Fluency Test and Category Fluency Test — 0.06…
Phase 4 N=80 Effect of Vascepa on Improving Coronary Atherosclerosis in People With High Triglycerides Taking Statin Therapy
Hypertriglyceridemia
Primary: Progression Rates of Low Attenuation Plaque Under Influence of Vascepa as Compared to Placebo as a Change Between Two or More Time Points — -0.3; 0.9 volume in mm cubed
Phase 2 N=14 Tolerability, Pharmacokinetics, and Efficacy of APD371 in Participants With Crohn's Disease Experiencing Abdominal Pain
Crohn's Disease · Abdominal Pain
Primary: Number of Participants With Treatment-Emergent Adverse Events (TEAEs) and Serious Adverse Events (SAEs) — 4; 6; 0; 1 Participants
Phase 4 N=581 Chemoprophylaxis Plus Early Ambulation
Pulmonary Embolism · Thoracic Surgery
Primary: Incidence of Postoperative Pulmonary Embolism (PE) in Surgical Thoracic Patients Under Currently Used PE Prevention Strategies. — 3 Participants
N/A N=25 Smart Touch Non-dispensing Handling Studies
Optometry
Primary: Number of Participants Without Contamination of Contact Lenses — 16; 9; 4; 14 Participants
Phase 2 N=240 CetuGEX™ in Comparison to Cetuximab for the Treatment of Patients With Head and Neck Cancer
Carcinoma, Squamous Cell of Head and Neck
Primary: Progression-free Survival (PFS) — 27.7; 26.4 weeks — p=0.86
Phase 2 N=56 Oral Desensitization to Peanut in Peanut-Allergic Children and Adults Using Characterized Peanut Allergen OIT
Peanut Allergy
Primary: The Percentage of Subjects Who Tolerate at Least 300 mg (443 mg Cumulative) of Peanut Protein With no More Than Mild Symptoms at the Exit DBPCFC — 23; 5 Participants…
N/A N=50 Initial Experience With Storz C-MAC Video Intubation System
Intubation; Difficult
Primary: Time for Intubation — 12.3; 9.8 seconds
Phase 2 N=264 Assessment of LBR-101 In Chronic Migraine
Chronic Migraine
Primary: Mean Change From Baseline in the Number of Monthly Cumulative Headache Hours of Any Severity on Headache Days Relative to the 28-day Post-treatment Period Ending With…